Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review | Zendy

Andrew B. Janowski | Zendy; Marian G. Michaels | Zendy; Judith M. Martin | Zendy; Michael D. Green | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review

Author(s) -

Andrew B. Janowski,

Marian G. Michaels,

Judith M. Martin,

Michael D. Green

Publication year - 2015

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piv036

Subject(s) - piperacillin/tazobactam , medicine , antimicrobial stewardship , antibiotic stewardship , piperacillin , tertiary care , tazobactam , pediatric hospital , stewardship (theology) , intensive care medicine , audit , antibiotics , emergency medicine , pediatrics , antibiotic resistance , microbiology and biotechnology , accounting , imipenem , genetics , politics , bacteria , law , political science , business , pseudomonas aeruginosa , biology

In this review of 200 charts, piperacillin-tazobactam usage was analyzed at a pediatric tertiary hospital, with an assessment of the indications for initiation, and continuation at day 3 of usage. Significant cost savings could be obtained with antibiotic stewardship audit on day 3 of antibiotic administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research